iovera system
by Myoscience, Inc. 2 variants
510(k) K173763
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK173763 | Date28 Feb 2018 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GXH
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.4250
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
The iovera system is a surgical cryogenic device classified under device class 2, intended for use in neurology-related applications. It is a handheld system designed to target specific nerves using cryoneurolysis technology.
The device is intended for use by or under the direction of a physician in settings such as a physician's office, ambulatory surgery center (ASC), or hospital-based outpatient department (HOPD). It is used across operative and non-operative treatment pathways in specialties including orthopedics, sports medicine, anesthesia, and pain management.
Other devices from Myoscience, Inc.
Questions
AI-generated answers, 6 Oct 2026
What is the iovera system used for?
The iovera system is intended for use in neurology-related applications, targeting specific nerves using cryoneurolysis technology across operative and non-operative treatment pathways in specialties including orthopedics, sports medicine, anesthesia, and pain management.
Who can operate the iovera system and where is it used?
The device is intended for use by or under the direction of a physician in settings such as a physician's office, ambulatory surgery center (ASC), or hospital-based outpatient department (HOPD).
What type of device is the iovera system and how is it designed?
The iovera system is a handheld surgical cryogenic device classified under device class 2, designed to target specific nerves using cryoneurolysis technology.